Efficacy of NF-kB Inhibition for Reducing Symptoms During Maintenance Therapy in Multiple Myeloma Patients

NCT01269203 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Curcumin
OTHER: Placebo

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]